<\/p>\n
NEW FILINGS<\/p>\n
Company: Vir Biotechnology, Inc.
\nSymbol: VIR
\nDescription: They are a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs, JP Morgan, Cowen, Barclays
\nFiled: 9-3-19
\nListed Cash Raise: $100m<\/p>\n
Company: Huize Holding Limited
\nSymbol: HUIZ
\nDescription: They are a leading independent online insurance product and service platform in China that is not affiliated with insurance companies or other insurance industry participants.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, Citigroup, CICC
\nCo-manager(s): Tiger Brokers
\nFiled:9-4-19
\nListed Cash Raise: $150m<\/p>\n
Company: MetroCity Bankshares Inc.
\nSymbol: MCBS
\nDescription: They are MetroCity Bankshares, Inc., a bank holding company headquartered in the Atlanta metropolitan area.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Keefe Bruyette & Woods, Raymond James
\nCo-manager(s): Hovde Group
\nFiled:9-4-19
\nListed Cash Raise: $40m<\/p>\n
TERMS ADDED<\/p>\n
Company: Cloudflare, Inc.
\nSymbol: NET
\nDescription: They have built a global cloud platform that delivers a broad range of network services to businesses of all sizes and in all geographies\u2014making them more secure, enhancing the performance of their business-critical applications, and eliminating the cost and complexity of managing individual network hardware.
\nShares: 35 million
\nPrice Range: $10.00-$12.00
\nMarket Cap: $2.93b-$3.52b
\nTrade Date: Friday, 9\/13
\nUnderwriter(s): Goldman Sachs, Morgan Stanley, J.P. Morgan, Jefferies, Wells Fargo Securities, RBC Capital Markets
\nCo-manager(s): JMP Securities, Evercore ISI, Needham & Company, Oppenheimer & Co., BTIG, SunTrust Robinson Humphrey
\nTerms Added: 9-3-19<\/p>\n
Company: SmileDirectClub, Inc.
\nSymbol: SDC
\nDescription: They are a direct to consumer medtech company for transforming smiles.
\nShares: 58.537 million
\nPrice Range: $19.00-$22.00
\nMarket Cap: $7.35b-$8.5b
\nTrade Date: Thursday, 9\/12
\nUnderwriter(s): J.P. Morgan, Citigroup, BofA Merrill Lynch,Jefferies, UBS Investment Bank, Credit Suisse
\nCo-manager(s): Guggenheim Securities, Stifel, William Blair, Loop Capital
\nTerms Added: 9-3-19<\/p>\n
Company: Envista Holdings Corporation
\nSymbol: NVST
\nDescription: Envista is one of the largest global dental products companies with significant market positions in some of the most attractive segments of the dental products industry, including implants, orthodontics and digital imaging technologies.
\nShares: 26.8 million
\nPrice Range: $21.00-$24.00
\nMarket Cap: $3.25b-$3.7bn
\nTrade Date: Wednesday, 9\/18
\nUnderwriter(s): JP Morgan, Goldman Sachs, Morgan Stanley
\nCo-Manager(s): Baird, Evercore ISI, Jefferies, BofA Merrill Lynch, Credit Suisse, Stifel, William Blair
\nTerms Added: 9-4-19, 9\/12
\nUnderwriter(s): J.P. Morgan, Citigroup, BofA Merrill Lynch,Jefferies, UBS Investment Bank, Credit Suisse
\nCo-manager(s): Guggenheim Securities, Stifel, William Blair, Loop Capital
\nTerms Added: 9-3-19<\/p>\n
Company: IGM Biosciences, Inc.
\nSymbol: IGMS
\nDescription: They are a biotechnology company pioneering the development of engineered IgM antibodies for the treatment of cancer patients.
\nShares: 7.8 million
\nPrice Range: $15.00-$17.00
\nMarket Cap: $390m-$440m
\nTrade Date: Wednesday, 9\/18
\nUnderwriter(s): Jefferies, Piper Jaffray, Stifel, Guggenheim Securities
\nTerms Added: 9-3-19<\/p>\n
Company: 10x Genomics, Inc.
\nSymbol: TXG
\nDescription: They are a life science technology company building products to interrogate, understand and master biology.
\nShares: 9 million
\nPrice Range: $31.00-$35.00
\nMarket Cap: $2.9b-$3.25b
\nTrade Date: Thursday, 9\/12
\nUnderwriter(s): JP Morgan, Goldman Sachs, BofA Merrill Lynch
\nCo-manager(s): Cowen
\nTerms Added: 9-3-19<\/p>\n
Company: Satsuma Pharmaceuticals, Inc.
\nSymbol: STSA
\nDescription: They are a clinical-stage biopharmaceutical company developing a novel therapeutic product for the acute treatment of migraine.
\nShares: 5 million
\nPrice Range: $14.00-$16.00
\nMarket Cap: $225m-$257m
\nTrade Date: Friday, 9\/13
\nUnderwriter(s): Credit Suisse, SVB Leerink, Evercore ISI
\nTerms Added: 9-3-19<\/p>\n
Company: SpringWorks Therapeutics, Inc.
\nSymbol: SWTX
\nDescription: They are a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer.
\nShares: 7.4 million
\nPrice Range: $16.00-$18.00
\nMarket Cap: $643m-$725m
\nTrade Date: Friday, 9\/13
\nUnderwriter(s): JP Morgan, Goldman Sachs, Cowen
\nCo-Manager: Wedbush PacGrow
\nTerms Added: 9-3-19<\/p>\n
Company: Alerus Financial Corporation
\nSymbol: ALRS
\nDescription: They are a diversified financial services company headquartered in Grand Forks, North Dakota.
\nShares: 3.25 million
\nPrice Range: $22.00-$24.00
\nMarket Cap: $375m-$410m
\nTrade Date: Thursday, 9\/12
\nUnderwriter(s): Raymond James, DA Davidson
\nCo-Manager: Piper Jaffray
\nTerms Added: 9-3-19<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,1536],"tags":[],"class_list":["post-9810","post","type-post","status-publish","format-standard","hentry","category-ipo","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/9810","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=9810"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/9810\/revisions"}],"predecessor-version":[{"id":9811,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/9810\/revisions\/9811"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=9810"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=9810"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=9810"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}